The role of native (not culture-expanded) joint-resident mesenchymal stem cells (MSCs) in
the repair of joint damage in osteoarthritis (OA) is poorly understood. MSCs differ from bone …

The ability of MSCs to modulate the inflammatory environment is well recognized, but
understanding the molecular mechanisms responsible for these properties is still far from …

Nonsteroidal anti‐inflammatory drugs (NSAIDs) play an essential part in our approach to
control pain in the posttraumatic setting. Over the last decades, several studies suggested …

Around 5 million annual births in EU and 131 million worldwide give a unique opportunity to
collect lifesaving Wharton's jelly derived mesenchymal stem cells (WJ‐MSC). Evidences that …

Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used for the treatment of
skeletal injuries. The ability of NSAIDs to reduce pain and inflammation is well-established …

Osteoarthritis (OA) is a potentially disabling disease whose progression is dependent on
several risk factors. OA management usually involves the use of non-steroidal anti …

For centuries, nonsteroidal anti-inflammatory drugs (NSAIDs) have been part of our clinical
practice. They started out as drugs with anti-inflammatory and analgesic action, and …

Materials and Methods: Trabecular bone was obtained from 10 patients (four males, mean
age 76 years) with lower extremity osteoporotic fractures. MSCs were isolated by enzymatic …

The pathogenesis of osteoarthritis is mediated in part by inflammatory cytokines including
interleukin-1 (IL-1), which promote degradation of articular cartilage and prevent human …

Burn injury is one of the potential causes of heterotopic ossification (HO), which is a rare but
debilitating condition. The incidence ranges from 3.5 to 5.6 depending on body area. Burns …